Qrons licenses 3D printing tech from Dartmouth Uni

US biotechnology company Qrons has obtained a world exclusive licence for IP related to 3D printable materials in the fields of human and animal health from Dartmouth University.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

3D Bioprinting: Can India capitalise on a growing trend?

1 August 2023 Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.

Americas

Federal Circuit rejects Dartmouth College bid to overturn patent ruling

14 February 2023 Dietary supplements containing a form of vitamin B3 found in cow’s milk are unpatentable | Judge cites Myriad noting that the “act of isolating the NR compared to how NR naturally exists in milk is not sufficient, on its own, to confer patent eligibility”.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Qrons licenses 3D printing tech from Dartmouth Uni

More on this story

Editor's picks

Editor's picks

More features